MeiDongMD

PubMed

• 12 citations
  Gemcitabine, dexamethasone, and cisplatin (GDP) as salvage chemotherapy for patients with relapsed or refractory peripheral T cell lymphoma—not otherwise specified
  Fei Qi, Mei Dong, Xiaohui He, Yexiong Li, Weihu Wang, Peng Liu, Jianliang Yang, Lin Gui, Changgong Zhang, Sheng Yang, Shengyu Zhou, Yuankai Shi> ;Annals of Hematology. 2017 Feb 1
• 13 citations
  Comparison of gemcitabin, cisplatin, and dexamethasone (GDP), CHOP, and CHOPE in the first-line treatment of peripheral T-cell lymphomas
  Bo Jia, Shaoxuan Hu, Jianliang Yang, Shengyu Zhou, Peng Liu, Yan Qin, Lin Gui, Sheng Yang, Hua Lin, Changgong Zhang, Puyuan Xing, Lin Wang, Mei Dong, Liqiang Zhou, Yan...> ;Hematology. 2016 Apr 6
• 25 citations
  GDP (Gemcitabine, Dexamethasone, and Cisplatin) Is Highly Effective and Well-Tolerated for Newly Diagnosed Stage IV and Relapsed/Refractory Extranodal Natural Killer/T...
  Jingjing Wang, Mei Dong, Xiaohui He, Ye-xiong Li, Weihu Wang, Peng Liu, Jianliang Yang, Lin Gui, Changgong Zhang, Sheng Yang, Shengyu Zhou, Yuankai Shi> ;Medicine. 2016 Feb 1
• [Duration of filgrastim prophylaxis for chemotherapy-induced neutropenia and its predictors].
  Sheng Yang, Xiaohui He, Peng Liu, Shengyu Zhou, Mei Dong, Yan Qin, Jianliang Yang, Changgong Zhang, Xiao-hong Han, Yuankai Shi> ;Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 2016 Jan 1
• Clinicopathological characteristics and prognostic analysis of primary intestinal diffuse large B-cell lymphoma
  Yu Huang, Shengyu Zhou, Xiaohui He, Lin Gui, Jianliang Yang, Peng Liu, Yan Qin, Changgong Zhang, Puyuan Xing, Sheng Yang, Lin Wang, Liqiang Zhou, Mei Dong, Yan Sun, Yu...> ;Zhonghua Yi Xue Za Zhi. 2015 Dec 19
• 2 citations
  Addition of rituximab is not associated with survival benefit compared with CHOP alone for patients with stage I diffuse large B-cell lymphoma.
  Bo Jia, Yuankai Shi, Suyi Kang, Sheng Yang, Shaoxuan Hu, Yexiong Li, Mei Dong, Weihu Wang, Jianliang Yang, Liqiang Zhou, Peng Liu, Shengyu Zhou, Yan Qin, Lin Gui, Chan...> ;Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu. 2015 Oct 23
• 2 citations
  Infection status and prognostic significance analysis of Epstein–Barr virus in 207 cases with newly diagnosed Hodgkin's lymphoma
  Suyi Kang, Yan Qin, Xiaohui He, Shengyu Zhou, Xiaohong Han, Peng Liu, Mei Dong, Liqiang Zhou, Jianliang Yang, Sheng Yang, Changgong Zhang, Lin Gui, Yuankai Shi> ;Zhonghua Yi Xue Za Zhi. 2015 Aug 25
• Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma.
  Shi Y, Dong M, Hong X, Zhang W, Feng J, Zhu J, Yu L, Ke X, Huang H, Shen Z, Fan Y, Li W, Zhao X, Qi J, Huang H, Zhou D, Ning Z, Lu X> ;Ann. Oncol.. 2015-08-01
• 2 citations
  [Clinicopathological features and outcomes: analysis of 21 cases of lymphoma in pregnancy].
  Lin Gui, Yuankai Shi, Xiaohui He, Liqiang Zhou, Mei Dong, Shengyu Zhou, Peng Yuan, Peng Liu, Jianliang Yang, Changgong Zhang, Yan Qin, Sheng Yang> ;Zhonghua Yi Xue Za Zhi. 2015 Feb 10
• 3 citations
  A pilot study of the safety and efficacy of dexamethasone, ifosfamide, methotrexate and gemcitabine chemotherapy for natural killer/T-cell lymphoma.
  Jianliang Yang, Yuankai Shi, Xiaohui He, Mei Dong, Changgong Zhang, Peng Liu, Shengyu Zhou, Yan Qin, Lin Gui, Sheng Yang, Yan Sun> ;Leukemia & Lymphoma. 2015 Jan 7
• [Efficacy analysis of different follow-up methods in detecting first recurrence of lymphoma].
  Jianliang Yang, Yuankai Shi, Xiaohui He, Shengyu Zhou, Mei Dong, Peng Liu, Li-qiang Zhou, Changgong Zhang, Yan Qin, Sheng Yang, Lin Gui> ;Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 2014 Dec 1
• Clinical features and prognostic analysis of mantle cell lymphoma patients
  Ping Zhou, Yuankai Shi, Xiaohui He, Shengyu Zhou, Peng Liu, Mei Dong, Yan Qin, Jianliang Yang, Changgong Zhang, Liqiang Zhou, Sheng Yang, Lin Gui> ;Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 2014 Dec 1
• 66 citations
  Plasma levels of heat shock protein 90 alpha associated with lung cancer development and treatment responses
  Yuankai Shi, Xiaoqing Liu, Jiatao Lou, Xiaohong Han, Lijian Zhang, Qingtao Wang, Baolan Li, Mei Dong, Yinghong Zhang> ;Clinical Cancer Research. 2014 Dec 1
• 7 citations
  Clinical features, survival and prognostic factors of primary testicular diffuse large B-cell lymphoma.
  Bo Jia, Yuankai Shi, Mei Dong, Feng-yi Feng, Sheng Yang, Hua Lin, Li-qiang Zhou, Shengyu Zhou, Shanshan Chen, Jianliang Yang, Peng Liu, Yan Qin, Changgong Zhang, Lin G...> ;Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu. 2014 Aug 28
• 45 citations
  Deficiency of the BiP cochaperone ERdj4 causes constitutive endoplasmic reticulum stress and metabolic defects
  Jill M. Fritz, Mei Dong, Karen S. Apsley, Emily P. Martin, Cheng-Lun Na, Sneha Sitaraman, Timothy E. Weaver> ;Molecular Biology of the Cell. 2014 Feb 15
• 2 citations
  Efficacy and safety evaluation of gemcitabine combined with oxaliplatin in lymphoma patients after failure of multiple chemotherapy regimens
  Jianliang Yang, Yuankai Shi, Xiaohui He, Shengyu Zhou, Mei Dong, Peng Liu, Changgong Zhang, Yan Qin, Sheng Yang, Lin Gui> ;Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 2014 Feb 1
• 20 citations
  High-dose therapy and autologous stem cell transplantation in peripheral T-cell lymphoma: treatment outcome and prognostic factor analysis
  Lin Gui, Yuankai Shi, Xiaohui He, Yingheng Lei, Hongzhi Zhang, Xiaohong Han, Shengyu Zhou, Peng Liu, Jiangliang Yang, Mei Dong, Changgong Zhang, Sheng Yang, Yan Qin> ;International Journal of Hematology. 2014 Jan 1
• Progress in cancer treatment with histone deacetylase inhibitor
  Mei Dong, Xingsheng Hu, Shanshan Chen, Puyuan Xing, Feng-yi Feng, Yuankai Shi> ;Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 2013 Jul 1
• 31 citations
  Gemcitabine-based combination regimen in patients with peripheral T-cell lymphoma.
  Mei Dong, Xiaohui He, Peng Liu, Yan Qin, Jianliang Yang, Shengyu Zhou, Sheng Yang, Changgong Zhang, Lin Gui, Li-qiang Zhou, Yuankai Shi> ;Medical Oncology. 2013 Mar 1
• [Clinical analysis of childhood and adolescent Hodgkin's lymphoma: a report of 88 cases].
  Puyuan Xing, Yuankai Shi, Xiaohui He, Liqiang Zhou, Mei Dong, Jianliang Yang, Peng Liu> ;Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 2012 Sep 1
• 4 citations
  Efficacy of peripheral blood stem cell transplantation versus conventional chemotherapy on anaplastic large-cell lymphoma:a retrospective study of 64 patients from a s...
  Xiaohui He, Bo Li, Shuang-mei Zou, Mei Dong, Shengyu Zhou, Jianliang Yang, Liyan Xue, Sheng Yang, Peng Liu, Yan Qin, Changgong Zhang, Xiaohong Han, Yuankai Shi> ;Chinese Journal of Cancer. 2012 Aug 2
• [Evaluation of the role of rhIL-11 on hematological recovery in lymphoma patients after autologous hematopoietic stem cell transplantation].
  Yang J, Shi Y, He X, Dong M, Zhou S, Liu P, Zhang C, Han X, Yang S, Gui L, Qin Y> ;Zhonghua Zhong Liu Za Zhi. 2012-06-01
• 10 citations
  R-CHOP regimen can significantly decrease the risk of disease relapse and progression in patients with non-germinal center B-cell subtype diffuse large B-cell lymphoma
  Xiaohui He, Bo Li, Sheng Yang, Ning Lu, Xun Zhang, Shuang-mei Zou, Yexiong Li, Yong-Wen Song, Shan Zheng, Mei Dong, Shengyu Zhou, Jianliang Yang, Peng Liu, Changgong Z...> ;Chinese Journal of Cancer. 2012 May 23
• [Comparative analysis of liver function in HBsAg-/HBcAb+ patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP regimens].
  Huang Y, He X, Qin Y, Yang S, Lü Z, Dong M, Zhou S, Liu P, Zhang C, Yang J, Shi Y> ;Zhonghua Zhong Liu Za Zhi. 2012-05-01
• 38 citations
  New Strategies for Advanced Neuroendocrine Tumors in the Era of Targeted Therapy
  Mei Dong, Alexandria T. Phan, James C. Yao> ;Clinical Cancer Research. 2012 Apr 1
• Join now to see all